Chang DY - Search Results

1

THOC2 expression and its impact on 5-fluorouracil resistance in glioblastoma multiforme.

Lee YJ, Jung JH, Chang DY, Kim MG, Bashyal N, Hwang WS, Woo HG, Paek SH, Suh-Kim H, Kim SS. Lee YJ, et al. Among authors: chang dy. Am J Cancer Res. 2023 Jun 15;13(6):2410-2425. eCollection 2023. Am J Cancer Res. 2023. PMID: 37424800 Free PMC article.

2

Neural induction with neurogenin1 increases the therapeutic effects of mesenchymal stem cells in the ischemic brain.

Kim SS, Yoo SW, Park TS, Ahn SC, Jeong HS, Kim JW, Chang DY, Cho KG, Kim SU, Huh Y, Lee JE, Lee SY, Lee YD, Suh-Kim H. Kim SS, et al. Among authors: chang dy. Stem Cells. 2008 Sep;26(9):2217-28. doi: 10.1634/stemcells.2008-0108. Epub 2008 Jul 10. Stem Cells. 2008. PMID: 18617687

3

The growth of brain tumors can be suppressed by multiple transplantation of mesenchymal stem cells expressing cytosine deaminase.

Chang DY, Yoo SW, Hong Y, Kim S, Kim SJ, Yoon SH, Cho KG, Paek SH, Lee YD, Kim SS, Suh-Kim H. Chang DY, et al. Int J Cancer. 2010 Oct 15;127(8):1975-83. doi: 10.1002/ijc.25383. Int J Cancer. 2010. PMID: 20473873 Free article.

4

Retrovirus-mediated transduction of a cytosine deaminase gene preserves the stemness of mesenchymal stem cells.

Park JS, Chang DY, Kim JH, Jung JH, Park J, Kim SH, Lee YD, Kim SS, Suh-Kim H. Park JS, et al. Among authors: chang dy. Exp Mol Med. 2013 Feb 22;45(2):e10. doi: 10.1038/emm.2013.21. Exp Mol Med. 2013. PMID: 23429359 Free PMC article.

5

Immune following suppression mesenchymal stem cell transplantation in the ischemic brain is mediated by TGF-β.

Yoo SW, Chang DY, Lee HS, Kim GH, Park JS, Ryu BY, Joe EH, Lee YD, Kim SS, Suh-Kim H. Yoo SW, et al. Among authors: chang dy. Neurobiol Dis. 2013 Oct;58:249-57. doi: 10.1016/j.nbd.2013.06.001. Epub 2013 Jun 10. Neurobiol Dis. 2013. PMID: 23759293 Free article.

6

Therapeutic effect of hepatocyte growth factor-secreting mesenchymal stem cells in a rat model of liver fibrosis.

Kim MD, Kim SS, Cha HY, Jang SH, Chang DY, Kim W, Suh-Kim H, Lee JH. Kim MD, et al. Among authors: chang dy. Exp Mol Med. 2014 Aug 22;46(8):e110. doi: 10.1038/emm.2014.49. Exp Mol Med. 2014. PMID: 25145391 Free PMC article.

7

Three-dimensional assessment of bystander effects of mesenchymal stem cells carrying a cytosine deaminase gene on glioma cells.

Jung JH, Kim AA, Chang DY, Park YR, Suh-Kim H, Kim SS. Jung JH, et al. Among authors: chang dy. Am J Cancer Res. 2015 Aug 15;5(9):2686-96. eCollection 2015. Am J Cancer Res. 2015. PMID: 26609476 Free PMC article.

8

Dihydropyrimidine Dehydrogenase Is a Prognostic Marker for Mesenchymal Stem Cell-Mediated Cytosine Deaminase Gene and 5-Fluorocytosine Prodrug Therapy for the Treatment of Recurrent Gliomas.

Chung T, Na J, Kim YI, Chang DY, Kim YI, Kim H, Moon HE, Kang KW, Lee DS, Chung JK, Kim SS, Suh-Kim H, Paek SH, Youn H. Chung T, et al. Among authors: chang dy. Theranostics. 2016 Jun 17;6(10):1477-90. doi: 10.7150/thno.14158. eCollection 2016. Theranostics. 2016. PMID: 27446484 Free PMC article.

9

Effects of Adenoviral Gene Transduction on the Stemness of Human Bone Marrow Mesenchymal Stem Cells.

Marasini S, Chang DY, Jung JH, Lee SJ, Cha HL, Suh-Kim H, Kim SS. Marasini S, et al. Among authors: chang dy. Mol Cells. 2017 Aug;40(8):598-605. doi: 10.14348/molcells.2017.0095. Epub 2017 Aug 10. Mol Cells. 2017. PMID: 28835020 Free PMC article.

10

Combined effects of mesenchymal stem cells carrying cytosine deaminase gene with 5-fluorocytosine and temozolomide in orthotopic glioma model.

Chang DY, Jung JH, Kim AA, Marasini S, Lee YJ, Paek SH, Kim SS, Suh-Kim H. Chang DY, et al. Am J Cancer Res. 2020 May 1;10(5):1429-1441. eCollection 2020. Am J Cancer Res. 2020. PMID: 32509389 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

235 results

Search Page